MA25590A1 - active agent dry powder Shipping Policy - Google Patents

active agent dry powder Shipping Policy


Publication number
MA25590A1 MA25762A MA25762A MA25590A1 MA 25590 A1 MA25590 A1 MA 25590A1 MA 25762 A MA25762 A MA 25762A MA 25762 A MA25762 A MA 25762A MA 25590 A1 MA25590 A1 MA 25590A1
Prior art keywords
active agent
dry powder
agent dry
shipping policy
Prior art date
Application number
Other languages
French (fr)
Clark Andrew
Chang Kuo Mei
John Aldous Barry
Lalor Cecily
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10016398P priority Critical
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of MA25590A1 publication Critical patent/MA25590A1/en



    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
MA25762A 1998-09-14 1999-09-09 active agent dry powder Shipping Policy MA25590A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10016398P true 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
MA25590A1 true MA25590A1 (en) 2002-12-31



Family Applications (1)

Application Number Title Priority Date Filing Date
MA25762A MA25590A1 (en) 1998-09-14 1999-09-09 active agent dry powder Shipping Policy

Country Status (41)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HU0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562D0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE10612000A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA1501B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198593C (en) 1999-06-09 2005-04-27 罗伯特·E·希弗斯 Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1392262A1 (en) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
NZ535323A (en) 2002-02-25 2008-02-29 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
WO2004004798A2 (en) * 2002-07-03 2004-01-15 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
ES2280835T3 (en) * 2002-12-19 2007-09-16 Pharmacia Corporation Non-hygroscopic formulation comprising a hygroscopic drug.
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N2- [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxochinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, processes for its preparation and its use as Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
DK2708225T3 (en) 2004-04-23 2019-04-08 Cydex Pharmaceuticals Inc DPI formulation containing sulfoalkyl ether cyclodextrin
CN101180257A (en) * 2005-02-24 2008-05-14 扩散药品有限公司 Trans carotenoids, their synthesis, formulation and uses
CN101171023A (en) * 2005-03-09 2008-04-30 小野药品工业株式会社 Particle and preparation containing the particle
PT1945228E (en) 2005-10-26 2011-07-13 Cydex Pharmaceuticals Inc Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
EA200970944A1 (en) 2007-04-13 2010-06-30 Диффьюжн Фармасьютикалз Ллс Application bipolar transkarotinoidov as a preliminary treatment for the treatment of peripheral vascular disease
CA2703946A1 (en) 2007-10-31 2009-05-07 Diffusion Pharmaceuticals Llc A new class of therapeutics that enhance small molecule diffusion
DK2432502T3 (en) 2009-05-20 2018-03-12 Aeras Stable spray-dried immunogenic compositions virus
JP5787884B2 (en) 2009-06-22 2015-09-30 ディフュージョン・ファーマシューティカルズ・エルエルシー Diffusion enhancing compounds, and their alone or in combination with thrombolytic agent
JP2013527231A (en) 2010-06-02 2013-06-27 ディフュージョン・ファーマシューティカルズ・エルエルシー Oral formulations of bipolar trans carotenoid
WO2013164380A1 (en) 2012-05-03 2013-11-07 Janssen R&D Ireland Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ES2177544T3 (en) * 1992-06-12 2002-12-16 Teijin Ltd ultrafinno powder inhaler and method for its preparation.
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
EP0954282B1 (en) * 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
CZ2001829A3 (en) 2001-09-12
SK3442001A3 (en) 2001-11-06
IL141562A (en) 2007-07-24
PE10612000A1 (en) 2000-10-08
HU0103837A3 (en) 2002-11-28
OA11781A (en) 2005-07-26
MY129282A (en) 2007-03-30
JP2002524535A (en) 2002-08-06
GEP20043257B (en) 2004-02-10
CA2343920A1 (en) 2000-03-23
YU24201A (en) 2003-08-29
BR9913722A (en) 2001-05-29
AP200102093A0 (en) 2001-03-31
SA1501B1 (en) 2006-11-04
EA200100300A1 (en) 2001-10-22
HU0103837A2 (en) 2002-05-29
BG105430A (en) 2001-12-31
PA8481901A1 (en) 2002-04-25
AU6039799A (en) 2000-04-03
HN1999000159A (en) 1999-11-11
PL346768A1 (en) 2002-02-25
NZ510168A (en) 2003-09-26
TR200101182T2 (en) 2001-09-21
DZ2892A1 (en) 2003-12-15
IS5878A (en) 2001-03-05
EA003476B1 (en) 2003-06-26
ZA200101995B (en) 2002-03-11
GT199900156A (en) 2001-03-07
EE200100151A (en) 2002-06-17
NO20011251D0 (en) 2001-03-13
HRP20010189A2 (en) 2005-04-30
IL141562D0 (en) 2002-03-10
LT2001021A (en) 2001-11-26
AU753014B2 (en) 2002-10-03
UA76085C2 (en) 2006-07-17
LV12658B (en) 2001-09-20
NO20011251L (en) 2001-04-17
AR022090A1 (en) 2002-09-04
CO5130023A1 (en) 2002-02-27
PL195574B1 (en) 2007-10-31
WO2000015262A1 (en) 2000-03-23
EP1117442A1 (en) 2001-07-25
AP1374A (en) 2005-02-28
ID28845A (en) 2001-07-05
LV12658A (en) 2001-05-20
CN1317977A (en) 2001-10-17
TNSN99173A1 (en) 2005-11-10
LT4897B (en) 2002-02-25
TWI226248B (en) 2005-01-11

Similar Documents

Publication Publication Date Title
DE60027306D1 (en) Ventilated footwear
DK1128729T3 (en) herbicidal composition
DE69942606D1 (en) Aerosol composition
DE60011446D1 (en) Substituted pyridinio pentaazamakrozykle complex activity superoxide dismutase-with
DE69928085D1 (en) Dosage form having prolonged release of active ingredient
NO20006163L (en) Loading arrangement
LU91343I2 (en) Byetta-Exenatide
DE69942754D1 (en) sprayer
NO20014859D0 (en) Quickly dispersible dosage forms containing fish gelatin
AT251740T (en) irradiator
NO20005077L (en) bicyclic hydroxamic acid derivatives
DE69815350D1 (en) Reloadable active transponder
DE69921196D1 (en) body protection
DE60037299D1 (en) Elektrolumineszensanzeige active matrix
DE60042878D1 (en) Elektrolumineszensanzeige active matrix
DE60012188D1 (en) fungicides
DE69807455D1 (en) Hydroxamic acid derivatives
AT281847T (en) Odor neutralizer
DE69919899D1 (en) inhalator
DE69923566D1 (en) microcapsules gel-coated
DE50012782D1 (en) irradiator
NO321599B1 (en) respiratory syncytialvirusreplikasjonsinhibitorer
DK0979654T3 (en) Emulsionslotioner active vitamin D 3
DK1209972T3 (en) herbicidal composition
DE69934135D1 (en) Taste masked dosage forms comprising active ingredients